异基因造血干细胞移植后巨细胞病毒肺炎34例临床研究
回顾性分析上海市第一人民医院411例异基因造血干细胞移植患者,34例(8.3%)发生CMV肺炎,中位发病时间为移植后53天,主要症状为咳嗽、发热和气促;支气管肺泡灌洗液CMV-DNA拷贝数高于血浆,年龄≥40岁和高流量通气为独立预后不良因素,总生存率58.82%。
要点
- allo-HSCT后CMV肺炎发生率8.3%,中位发病53天,典型症状为咳嗽、发热、气促。
- BALF的CMV-DNA拷贝数显著高于血浆,有助于提高病原学诊断准确性。
- 年龄≥40岁和高流量通气是CMV肺炎患者独立预后不良因素。
核心结论
- 支气管镜肺泡灌洗液检测有助于提升allo-HSCT后CMV肺炎病原学诊断的准确性。
- 年龄≥40岁及接受高流量通气是CMV肺炎患者独立预后不良因素。
研究设计与样本
- 回顾性分析2016年3月1日至2019年6月30日上海市第一人民医院血液科411例allo-HSCT患者的临床资料。
- 其中34例(8.3%)移植后发生CMV肺炎,男18例、女16例,中位年龄32(8~62)岁。
- 原发病包括急性髓系白血病14例、急性淋巴细胞白血病10例、骨髓增生异常综合征5例、非霍奇金淋巴瘤3例、再生障碍性贫血2例。
主要发现
- CMV肺炎中位发病时间为移植后53(36~506)d。
- 主要症状为咳嗽(26例,76.5%)、发热(23例,67.6%)、气促(14例,41.2%),仅17.6%(6/34)有咯痰,2例(5.9%)早期无症状经胸部CT发现。
- 28例(82.4%)影像学表现为小叶中心结节、弥漫毛玻璃影等典型间质性肺炎改变,6例(17.6%)为斑片、结节及实变样不典型改变。
- 26例(76.5%)血浆CMV-DNA阳性,拷贝数低于同期BALF[1.70×10^7(5.44×10^5~4.45×10^9)拷贝/L对1.45×10^8(1.10×10^7~1.10×10^11)拷贝/L,P=0.004]。
- 13例(38.2%)合并其他下呼吸道病原体感染(真菌10株、细菌6株、腺病毒1株);中位随访12.8(0.4~46.5)个月,总生存率58.82%。
关键数值与推荐
- CMV肺炎诊断依据临床表现、影像学及血浆/BALF CMV-DNA检测。
- 年龄≥40岁和高流量通气为独立预后不良因素(P=0.049,P=0.009)。
临床怎么用
- 对allo-HSCT后怀疑CMV肺炎者,应尽早行支气管镜肺泡灌洗液CMV-DNA检测以提高病原学诊断准确性。
- 对年龄≥40岁或需要高流量通气的CMV肺炎患者,应加强监护和预后评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To analyze the clinical features and prognosis of cytomegalovirus pneumonia after allogeneic hematopoietic stem cell transplantation(allo-HSCT). Methods: We reviewed the clinical features and laboratory data of cytomegalovirus pneumonia patients after allogeneic peripheral blood HSCT from March 1, 2016 to June 30, 2019 at the hematology department of the Shanghai general hospital and analyze the prognostic factors. Results: Of the 411 allo-HSCT patients, 34(8.3%)developed CMV pneumonia after transplantation, including 18 men and 16 women, with a median age of 32(8-62)y. Total 14 patients had acute myeloid leukemia, 10 had acute lymphoblastic leukemia, 5 had myelodysplastic syndrome, 3 had non-Hodgkin's lymphoma, and 2 had aplastic anemia. The median onset time for CMV pneumonia was 53(36-506)d after transplantation. The main symptoms were cough(26 cases, 76.5%), fever(23 cases, 67.6%), and shortness of breath(14 cases, 41.2%). Only 17.6%(6/34)patients had expectoration, and 2 cases(5.9%)had no obvious symptoms in the early stage, but were diagnosed on routine chest CT examination. Twenty-eight(82.4%)patients showed signs of typical interstitial pneumonia, such as lobular central nodule and diffuse ground glass opacity; 6(17.6%)patients showed atypical imaging changes of patch, nodule, and consolidation. Further, 26 patients(76.5%)were positive for CMV-DNA, and the copy number was lower than that of BALF[1.70×10(7)(5.44×10(5)-4.45×10(9))copies/L vs 1.45×10(8)(1.10×10(7)-1.10×10(11))copies/L, P=0.004]. Thirteen(38.24%)patients with CMV pneumonia had mixed infection with other lower respiratory tract pathogens(10 strains of fungi, 6 strains of bacteria, and 1 of adenoviruses). The median follow-up duration was 12.8(0.4-46.5)months. The OS rate was 58.82%. Age ≥ 40 y and high flow ventilation were independent risk factors for poor prognosis in CMV pneumonia patients(P=0.049, P=0.009). Conclusion: Bronchoscopic bronchoalveolar lavage fluid detection helps in improving the accuracy of the etiological diagnosis of CMV pneumonia after allo-HSCT. Age ≥ 40 y and high flow ventilation were independent risk factors for poor prognosis in patients with CMV pneumonia. 目的: 分析异基因造血干细胞移植(allo-HSCT)后巨细胞病毒(CMV)肺炎的临床特点及预后。 方法: 对2016年3月1日至2019年6月30日在上海市第一人民医院血液科接受allo-HSCT后并发CMV肺炎的患者进行回顾性分析。 结果: ①全部411例allo-HSCT患者中,34例(8.3%)移植后发生CMV肺炎,其中男18例,女16例,中位年龄32(8~62)岁;急性髓系白血病14例,急性淋巴细胞白血病10例,骨髓增生异常综合征5例,非霍奇金淋巴瘤3例,再生障碍性贫血2例。②CMV肺炎中位发病时间为移植后53(36~506)d,主要症状为咳嗽(26例,76.5%)、发热(23例,67.6%)及气促(14例,41.2%),仅17.6%(6/34)的患者有咯痰,2例(5.9%)患者早期无明显症状而在常规胸部CT检查时发现。28例(82.4%)患者的影像学表现为小叶中心结节、弥漫毛玻璃影等典型间质性肺炎改变,6例(17.6%)表现为斑片、结节以及实变样不典型影像学改变。③26例(76.5%)患者血浆CMV-DNA阳性,拷贝数低于同期BALF检测结果[1.70×10(7)(5.44×10(5)~4.45×10(9))拷贝/L对1.45×10(8)(1.10×10(7)~1.10×10(11))拷贝/L,P=0.004]。④13例(38.2%)CMV肺炎患者合并其他下呼吸道病原体感染(真菌10株,细菌6株,腺病毒1株)。⑤所有患者中位随访时间12.8(0.4~46.5)个月,总生存率为58.82%,年龄≥40岁、接受高流量通气是CMV肺炎患者独立预后不良因素(P=0.049,P=0.009)。 结论: 气管镜肺泡灌洗液检测有助于提升allo-HSCT后CMV肺炎病原学诊断的准确性。年龄≥40岁及接受高流量通气是CMV肺炎患者独立预后不良因素。.
引用
- Li S, Shen ZH, Wan LP, et al. [Clinical study of 34 patients with cytomegalovirus pneumonia after allogeneic hematopoietic stem cell transplantation]. Zhonghua Xue Ye Xue Za Zhi. 2020. PMID: 33190442. doi:10.3760/cma.j.issn.0253-2727.2020.10.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。